Angiogenesis
During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
B1408 CNX-774Summary: BTK inhibitor, orally active, irreversible and selective
-
A3302 CGI-17461 CitationTarget: BTKSummary: Btk inhibitor
-
A3206 AVL-292Summary: Btk inhibitor
-
A8636 RN486Summary: Btk inhibitor,potent and selective
-
B3242 PCI-32765 RacemateSummary: BTK inhibitor
-
B3243 Btk inhibitor 1 R enantiomerSummary: Btk kinase inhibitor
-
A3001 PCI-32765 (Ibrutinib)4 CitationSummary: Bruton's tyrosine kinase (BTK) inhibitor
-
B6185 ACP-196Target: BTKSummary: irreversible BTK inhibitor
-
B5952 LFM-A13Summary: BTK-specific tyrosine kinase inhibitor
-
B5941 ONO-4059Summary: Highly potent and selective oral Btk inhibitor